- Home
- ESS vs SNN Comparison
ESS vs SNN Comparison
Compare ESS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESS | SNN |
|---|---|---|
| Founded | 1971 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Real Estate Investment Trusts | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 14.3B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | ESS | SNN |
|---|---|---|
| Price | $263.31 | $31.22 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 16 | 2 |
| Target Price | ★ $279.90 | $36.25 |
| AVG Volume (30 Days) | 391.9K | ★ 1.0M |
| Earning Date | 04-28-2026 | 03-16-2026 |
| Dividend Yield | ★ 3.91% | 2.48% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.65 | N/A |
| Revenue | ★ $1,887,345,000.00 | N/A |
| Revenue This Year | $1.84 | $8.58 |
| Revenue Next Year | $3.35 | $5.60 |
| P/E Ratio | $159.10 | ★ $64.97 |
| Revenue Growth | ★ 6.36 | N/A |
| 52 Week Low | $238.46 | $28.02 |
| 52 Week High | $294.09 | $38.79 |
Technical Indicators
Market Signals| Indicator | ESS | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 61.57 | 39.57 |
| Support Level | $252.07 | N/A |
| Resistance Level | $270.67 | $33.89 |
| Average True Range (ATR) | 5.83 | 0.57 |
| MACD | 1.32 | -0.24 |
| Stochastic Oscillator | 68.49 | 18.00 |
Price Performance
Historical ComparisonAbout ESS Essex Property Trust Inc.
Essex Property Trust owns a portfolio of 259 apartment communities with over 63,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.